Bluebird Bio Correlations

BLUE Stock  USD 8.35  0.09  1.09%   
The current 90-days correlation between Bluebird bio and Mersana Therapeutics is -0.03 (i.e., Good diversification). The correlation of Bluebird Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Bluebird Bio Correlation With Market

Good diversification

The correlation between Bluebird bio and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bluebird bio and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bluebird bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

Moving against Bluebird Stock

  0.46VCEL Vericel Corp OrdPairCorr
  0.5VTRS ViatrisPairCorr
  0.37DVAX Dynavax TechnologiesPairCorr
  0.32KTTAW Pasithea TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
VKTXYMAB
AGIOMRSN
ZNTLMRSN
HEPAYMAB
HEPAVKTX
AGIOZNTL
  
High negative correlations   
PTCTVKTX
PTCTYMAB
VKTXMDGL
MDGLYMAB
PTCTHEPA
SRPTMDGL

Risk-Adjusted Indicators

There is a big difference between Bluebird Stock performing well and Bluebird Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bluebird Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MRSN  5.51 (1.43) 0.00 (0.63) 0.00 
 9.05 
 64.16 
ZNTL  4.45 (0.26) 0.00 (0.30) 0.00 
 8.36 
 37.75 
YMAB  2.70 (1.24) 0.00 (2.55) 0.00 
 3.07 
 20.65 
TVTX  2.15  0.10  0.04  0.14  2.41 
 4.84 
 20.58 
MDGL  2.90  0.56  0.16  0.80  3.01 
 5.53 
 33.61 
VKTX  3.33 (0.95) 0.00 (1.11) 0.00 
 4.89 
 39.28 
SRPT  1.84 (0.06) 0.00 (0.14) 0.00 
 3.38 
 18.92 
HEPA  4.89 (0.08) 0.00 (0.22) 0.00 
 9.33 
 41.03 
PTCT  2.60  0.22  0.08  0.90  2.58 
 6.61 
 23.75 
AGIO  3.06 (0.28) 0.00 (0.33) 0.00 
 6.76 
 31.56 

Bluebird Bio Corporate Management

Mr MDChief OfficerProfile
Melissa BonnerVP ResearchProfile
Andrea WaltonChief OfficerProfile
JD EsqChief SecretaryProfile
Christopher CPAPrincipal CFOProfile